Product details

As with most acquisitions or divestitures, this deal contains its own unique circumstances. Both offers currently being entertained by WR Grace are from, for the most part, dialysis product manufacturers. Because the United States dialysis market is fairly mature, these two manufacturers are desperate to maintain market share. So in a sense, from the buyers perspective, this acquisition of National Medical Care could be categorized as a ''defensive'' acquisition. As a result, this vertical acquisition scenario creates significant leverage for WR Grace in its negotiations with Baxter and Fresenius. To make matters more interesting, as the deal progresses, an investigation by the US government begins, and the question of the assumption of a future potential liability becomes a key concern by all parties.